The Nephrotoxicity of Antimicrobial Agents

New England Journal of Medicine

Volumn 296, Issue 12, 1977, Pages 663-670

  Appel, Gerald B ^a   Neu, Harold C ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; PENICILLIN G;

ADVERSE DRUG REACTION; DOSE KIDNEY FUNCTION RELATION; HYPOKALEMIA; NEPHRON; NEPHROTOXICITY; REVIEW; SURVEY;

ANIMAL; ANTIBIOTICS; CATS; CEPHALOSPORINS; DOGS; DRUG SYNERGISM; GUINEA PIGS; HAPLORHINI; HUMAN; HYPOKALEMIA; IMMUNOGLOBULINS; KIDNEY; KIDNEY DISEASES; KIDNEY FAILURE, ACUTE; MICE; NEPHRITIS, INTERSTITIAL; PENICILLINS; RABBITS; WATER-ELECTROLYTE IMBALANCE;

EID: 0017614907     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197703242961205     Document Type: Review

References (83)

1. Schreiner GE, Maher JF: Toxic nephropathy. Am J Med 38: 409–449, 1965
2. Dettli LC: Drug dosage in patients with renal disease. Clin Pharmacol Ther 16: 241–280, 1974
3. Neu HC: Guidelines to antibiotic therapy in renal failure. Med Times 101: 47–54, 1973
4. Kunin CM: Antibiotic usage in patients with renal impairment. Hosp Prac 7: 141–149, 1972
5. Whelton A: Antibacterial chemotherapy in renal insufficiency: a review. Antibiot Chemother 18: 1–48, 1974
6. Cutler RE, Orme BM: Correlations of serum creatinine concentration and kanamycin half-life: therapeutic indications. JAMA 209: 539–542, 1969
7. Goodman EL, Van Gelder J, Holmes R, et al: Prospective comparative study of variable dosage and variable frequency regimens for administration of gentamicin. Antimicrob Agents Chemother 8: 434–438, 1975
8. Fishman LS, Hewitt WL: The natural penicillins. Med Clin North Am 54: 1081–1099, 1970
9. Weinstein L: The penicillins. The Pharmacological Basis of Therapeutics. Fifth edition. Edited by LS Goodman, A Gilman. New York, Macmillan, 1975, pp 1130–1166
10. Mercer CW, Logic JR: Cardiac arrest due to hyperkalemia following intravenous penicillin administration. Chest 64: 358–359, 1973
11. Brunner FP, Frick PG: Hypokalaemia, metabolic alkalosis, and hypernatraemia due to “massive” sodium penicillin therapy. Br Med J 4: 550–552, 1968
12. Hoffbrand BI, Stewart JDM: Carbenicillin and hypokalaemia. Br Med J 4: 746, 1970
13. Lipner HI, Ruzany F, Dasgupta M, et al: The behavior of carbenicillin as a nonreabsorbable anion. J Lab Clin Med 86: 183–194, 1975
14. Tattersall MHN, Battersby G, Spiers ASD: Antibiotics and hypokalaemia. Lancet 1: 630–631, 1972
15. Klastersky J, Vanderkelen B, Daneau D, et al: Carbenicillin and hypokalemia. Ann Intern Med 78: 774–775, 1973
16. Anderson AB: Anaphylactic purpura following intramuscular penicillin therapy. Med J Aust 1: 305–306, 1947
17. Kovnat P, Labovitz E, Levison S: Antibiotics and the kidney. Med Clin North Am 57: 1045–1063, 1973
18. Spring M: Purpura and nephritis after administration of procaine penicillin. JAMA 147: 1139–1141, 1951
19. Schrier RW, Bulger RJ, VanArsdel PP Jr: Nephropathy associated with penicillin and homologues. Ann Intern Med 64: 116–127, 1966
20. Peters GA, Moskowitz RW, Prickman LE, et al: Fatal necrotizing angiitis associated with hypersensitivity to penicillin O and iodides: report of a case. J Allergy 31: 455–467, 1960
21. Baldwin DS, Levine BB, McCluskey RT, et al: Renal failure and interstitial nephritis due to penicillin and methicillin. N Engl J Med 279: 1245–1252, 1968
22. Carré IJ, Squire JR: Anuria ascribed to acute tubular necrosis in infancy and early childhood. Arch Dis Child 31: 512–522, 1956
23. Zilberg B: Anuria following penicillin administration. S Afr Med J 32: 350–352, 1958
24. Colvin RB, Burton JR, Hyslop NE Jr, et al: Penicillin-associated interstitial nephritis. Ann Intern Med 81: 404–405, 1974
25. Brauninger GR, Remington JS: Nephropathy associated with methicillin therapy. JAMA 203: 103–105, 1968
26. Feigin RD, Fiascone A: Hematuria and proteinuria associated with methicillin administration. N Engl J Med 272: 903–904, 1965
27. Jensen HA, Halveg AB, Saunamäki KI: Permanent impairment of renal function after methicillin nephropathy. Br Med J 4: 406, 1971
28. Heptinstall RH: Interstitial nephritis: a brief review. Am J Pathol 83: 214–236, 1976
29. Ooi BS, First MR, Pesce AJ, et al: IgE levels in interstitial nephritis. Lancet 1: 1254–1256, 1974
30. Border WA, Lehman DH, Egan JD, et al: Antitubular basement-membrane antibodies in methicillin-associated interstitial nephritis. N Engl J Med 291: 381–384, 1974
31. Sanjad SA, Haddad GG, Nassar VH: Nephropathy, an underestimated complication of methicillin therapy. J Pediatr 84: 873–877, 1974
32. Tannenberg AM, Wicher KJ, Rose NR: Ampicillin nephropathy. JAMA 218: 449, 1971
33. Maxwell D, Szwed JJ, Wahle W, et al: Ampicillin nephropathy. JAMA 230: 586–587, 1974
34. Ruley EJ, Lisi LM: Interstitial nephritis and renal failure due to ampicillin. J Pediatr 84: 878–881, 1974
35. Parry MF, Ball WD, Conte JE Jr, et al: Nafcillin nephritis. JAMA 225: 178, 1973
36. Burton JR, Lichtenstein NS, Colvin RB, et al: Acute interstitial nephritis of oxacillin. Johns Hopkins Med J 134: 58–61, 1974
37. Engle JE, Drago J, Carlin B, et al: Reversible acute renal failure after cephalothin. Ann Intern Med 83: 232–233, 1975
38. Burton JR, Lichtenstein NS, Colvin RB, et al: Acute renal failure during cephalothin therapy. JAMA 229: 679–682, 1974
39. Pasternak DR, Stephens BG: Reversible nephrotoxicity associated with cephalothin therapy. Arch Intern Med 135: 599–602, 1975
40. Carling PC, Idelson BA, Casano A, et al: Nephrotoxicity associated with cephalothin administration. Arch Intern Med 135: 797–801, 1975
41. Saslaw S: Cephalosporins. Med Clin North Am 54: 1217–1228, 1970
42. Kunin CM, Atuk N: Excretion of cephaloridine and cephalothin in patients with renal impairment. N Engl J Med 274: 654–656, 1966
43. Silverblatt F, Harrison WO, Turck M: Nephrotoxicity of cephalosporin antibiotics in experimental animals. J Infect Dis 128: Suppl: 267–372, 1973
44. Benner EJ: Renal damage associated with prolonged administration of ampicillin, cephaloridine, and cephalothin. Antimicrob Agents Chemother 9: 417–420, 1969
45. Tune BM: Relationship between the transport and toxicity of cephalosporins in the kidney. J Infect Dis 132: 189–194, 1975
46. Cohen SN, Conte JE Jr: Drug-induced nephropathy. JAMA 227: 325, 1974
47. Kleinknecht D, Ganeval D, Droz D: Acute renal failure after high doses of gentamicin and cephalothin. Lancet 1: 1129, 1973
48. Fillastre JP, Laumonier R, Humbert G, et al: Acute renal failure associated with combined gentamicin and cephalothin therapy. Br Med J 2: 396–397, 1973
49. Bobrow SN, Jaffe E, Young RC: Anuria and acute tubular necrosis associated with gentamicin and cephalothin. JAMA 222: 1546–1547, 1972
50. Plager JE: Association of renal injury with combined cephalothin-gentamicin therapy among patients severely ill with malignant disease. Cancer 37: 1937–1943, 1976
51. Cabanilles F, Burgos R, Rodriguez RC, et al: Nephrotoxicity of combined cephalothin-gentamicin regimen. Arch Intern Med 135: 85–92, 1975
52. Optiz A, Herrman I, Herrath D, et al: Akute nierinsuffizienz nach Gentamicin-Cephalosporin Kombinations-Therapie. Med Welt 11: 434–438, 1971
53. Hollenberg NK, Adams DF, Oken DE, et al: Acute renal failure due to nephrotoxins: renal hemodynamic and angiographic studies in man. N Engl J Med 282: 1329–1334, 1970
54. Koch-Weser J, Sidel VW, Federman EB, et al: Adverse effects of sodium colistimethate: manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med 72: 857–868, 1970
55. Adler S, Segal DP: Nonoliguric renal failure secondary to sodium colistimethate: a report of four cases. Am J Med Sci 262: 109–114, 1971
56. Klastersky J, Hensgens C, Debusscher L: Empiric therapy for cancer patients: comparative study of ticarcillin-tobramycin, ticarcillin-cephalothin and cephalothin-tobramycin. Antimicrob Agents Chemother 7: 640–645, 1975
57. Turrcotte JG, Herrmann TJ, Haig O, et al: Oliguria following transplantation of kidneys donated by blood relatives. Surg Gynecol Obstet 130: 29–36, 1970
58. Pickering MJ, Spooner GR, de Quesda A, et al: Declining renal function associated with administration of cephalothin. South Med J 63: 426–428, 1970
59. Harrison WO, Silverblatt FJ, Turck M: Gentamicin nephrotoxicity: failure of three cephalosporins to potentiate injury in rats. Antimicrob Agents Chemother 8: 209–215, 1975
60. Fanning WL, Jick H, Gump DW: Rising BUN with gentamicin, cephalothin or both, Program and Abstracts: Fifteenth Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, September 24–26, 1975, abstract 402
61. Gaya H, Klastersky J, Schimpff SC: Nephrotoxicity during combined therapy with gentamicin and cephalothin, Program and Abstracts: Fifteenth Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, September 24–26, 1975, abstract 401
62. Mandell GL: Cephaloridine. Ann Intern Med 79: 561–565, 1973
63. Atkinson RM, Currie JP, Davis B, et al: Acute toxicity of cephaloridine, an antibiotic derived from cephalosporin C. Toxicol Appl Pharmacol 8: 398–406, 1966
64. Perkins RL, Apicella MA, Lee IS, et al: Cephaloridine and cephalothin: comparative studies of potential nephrotoxicity. J Lab Clin Med 71: 75–84, 1968
65. Currie GA, Little PJ, McDonald SJ: The localisation of cephaloridine and nitrofurantoin in the kidney. Nephron 3: 282–288, 1966
66. Silverblatt F, Turck M, Bulger R: Nephrotoxicity due to cephaloridine: a light- and electron-microscopic study in rabbits. J Infect Dis 122: 33–44, 1970
67. Dodds MG, Foord RD: Enhancement by potent diuretics of renal tubular necrosis induced by cephaloridine. Br J Pharmacol 40: 227–236, 1970
68. Linton AL, Bailey PR, Turnbull DI: Relative nephrotoxicity of cephalosporin antibiotics in an animal model. Can Med Assoc J 107: 414–416, 1972
69. Tune B, Kempson RL: Nephrotoxic drugs. Br Med J 3: 635, 1973
70. Boyd JF, Butcher BT, Stewart GT: The nephrotoxic effect of cephaloridine and its polymers. Int J Clin Pharmacol 7: 307–315, 1973
71. Dillon ML, Postlewait RW: Cephaloridine in patients with impaired renal function. JAMA 218: 250–251, 1971
72. Kleinknecht D, Jungers P, Fulastre J-P: Nephrotoxicity of cephaloridine. Ann Intern Med 80: 421–422, 1974
73. Rosenthal T, Boichis H: Nephrotoxicity of cephaloridine. Br Med J 4: 115, 1971
74. Hewitt WL: The cephalosporins. J Infect Dis 128: Suppl: 312–319, 1973
75. Kirby WMM, Regamey C: Pharmacokinetics of cefazolin compared with four other cephalosporins. J Infect Dis 128: Suppl: 341–346, 1973
76. Craig WA, Welling PG, Jackson JC, et al: Pharmacology of cefazolin and other cephalosporins in patients with renal insufficiency. J Infect Dis 128: Suppl: 347–353, 1973
77. Levison ME, Levison SP, Ries K, et al: Pharmacology of cefazolin in patients with normal and abnormal renal function. J Infect Dis 128: Suppl: 354–357, 1973
78. Birkhead HA, Briggs GB, Saunders LZ: Toxicity of cefazolin in animals. J Infect Dis 128: Suppl: 379–381, 1973
79. Turck M, Clark RA, Beaty HN, et al: Cefazolin in the treatment of bacterial pneumonia. J Infect Dis 128: Suppl: 382–385, 1973
80. Reinarz JA, Kier CM, Guckian JC: Evaluation of cefazolin in the treatment of bacterial endocarditis and bacteremias. J Infect Dis 128: Suppl: 392–395, 1973
81. Kunin CM, Furkleberg Z: Oral cephalexin and ampicillin: antimicrobial activity, recovery in urine, and persistence in blood of uremic patients. Ann Intern Med 72: 349–356, 1970
82. Fung-Herrera CG, Mulvaney WP: Cephalexin nephrotoxicity: reversible nonoliguric acute renal failure and hepatotoxicity associated with cephalexin therapy. JAMA 229: 318–319, 1974
83. Young GP, Sullivan J, Hurley T: Hypokalaemia due to gentamicin/cephalexin in leukaemia. Lancet 2: 855, 1973